metricas
covid
Buscar en
Clinics
Toda la web
Inicio Clinics ERRATA
Journal Information
Vol. 66. Issue 7.
Pages 1305 (July 2011)
Share
Share
Download PDF
More article options
Visits
510
Vol. 66. Issue 7.
Pages 1305 (July 2011)
ERRATA
Open Access
ERRATA
Visits
510
Related content
João Agostinho Machado-Neto, Fabiola Traina, Mariana Lazarini, Paula de Melo Campos, Katia Borgia Barbosa Pagnano, Irene Lorand-Metze, Fernando Ferreira Costa, Sara T Olalla Saad
Mohammed Rabbani, Seyed Ebrahim Sajjadi, Masoud Sadeghi
Juliana Hypólito Silva, Bianca Costa Soares de Sá, Alexandre Leon Ribeiro de Ávila, Gilles Landman, João Pedreira Duprat Neto
This item has received

Under a Creative Commons license
Article information
Full Text
CLINICS 2011;66(3):493-499

Page 493

Replace Juliana Hypólito Silva,I de Sá BC,II Alexandre Leon Ribeiro de Ávila,II Gilles Landman,III João Pedreira Duprat NetoII

For Juliana Hypólito Silva,I Bianca Costa Soares de Sá,II Alexandre Leon Ribeiro de Ávila,II Gilles Landman,III João Pedreira Duprat NetoII

Page 493 (Abstract)

Replace Silva JH, de Sá BCS, Avila ALR, Landman G, Duprat Neto JP. Atypical mole syndrome and dysplastic nevil: identification of populations at risk for developing melanoma – review article. Clinics. 2011;66(3):493-499.

For Silva JH, de Sá BC, Avila ALR, Landman G, Duprat Neto JP. Atypical mole syndrome and dysplastic nevil: identification of populations at risk for developing melanoma – review article. Clinics. 2011;66(3):493-499.

CLINICS 2011;66(5):793-799

Page 793 (Abstract/Results)

Replace These results show that hotspot mutations in the PI3K, JAK2, FLT3 and NPM1 genes are not common in MDS patients; nevertheless, JAK2 mutations may be present in myelodysplasia during disease progression.

For In the genes studied, no mutations were detected in the patients at the time of diagnosis. One patient with chronic myelomonocytic leukemia was heterozygous for a Janus kinase 2 mutation after disease progression.

CLINICS 2011;66(5):843-848

Page 843

Replace Chemical composition of the essential oil from kelussia odoratissima mozaff. and the evaluation of its sedative and anxiolytic effects in mice

For Chemical composition of the essential oil from Kelussia odoratissima Mozaff. and the evaluation of its sedative and anxiolytic effects in mice

ReplaceI Department of Pharmacognosy, School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran. II Department of Pharmacology, School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran. III Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran.

ForI Department of Pharmacology, School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran. II Department of Pharmacognosy, School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran. III Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran.

Copyright © 2011. CLINICS
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos